Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Vascular marker of ovarian cancer identified

24.09.2008
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.

"The laboratory of Dr. George Coukos is developing novel treatments for ovarian cancer which target the vasculature surrounding the tumor, thereby disrupting the blood supply needed for the tumor to grow," said Chunsheng Li, Ph.D., a post-doctoral research fellow at the University of Pennsylvania Ovarian Cancer Research Center.

Li presented his findings at the American Association for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development meeting being held here September 22-25, 2008.

Ovarian cancer is the deadliest gynecologic cancer in the United States, largely due to the fact that there are no reliable methods for detecting ovarian cancer at an early stage, when cure is still possible. Li and colleagues found that high levels of TEM1 were correlated with decreased survival of ovarian cancer patients. Furthermore, all 52 samples of ovarian cancer examined were positive for TEM1 in the vasculature, while none of the control samples tested positive. This suggests that TEM1 is a specific marker for ovarian cancer, which may lead to a potential screening tool.

Li and colleagues have been addressing TEM1's diagnostic value both in vitro and in vivo. In vitro, they used polymerase chain reaction and immunohistochemistry analyses to determine the relative levels of human TEM1 expression in ovarian cancer versus healthy human samples, and in vivo they developed PET imaging studies. Li's preliminary in vivo experiments with a new mouse model implanted with tumor vasculature that expresses human TEM1, demonstrated by PET imaging that a novel anti-TEM1 radiolabel probe could specifically detect a small number of TEM1-expresser cells.

Li said the specific expression of TEM1 by ovarian cancer tumor vasculature, is linked to poor prognosis and the development of new tools able to detect a small number of TEM1-expresser cells in vivo, will allow clinicians to more effectively target the tumor vasculature for diagnostic purposes as well as for treatments that could help halt the disease.

"This will have to be borne out in further studies, but if we can normalize the vasculature surrounding the tumor, we will have a better chance of eradicating the tumor," said Li.

Jeremy Moore | EurekAlert!
Further information:
http://www.aacr.org

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>